Skip to main content
. 2018 May 29;7:212527. doi: 10.7573/dic.212527

Table 5.

Advantages and disadvantages of new drugs for P. aeruginosa infections.

Advantages
 High activity against P. aeruginosa including MDR strains

 Predictable PK

 Good safety profile and tolerability

 Carbapenem sparing

 Rapid tissue distribution

Disadvantages

 Increased costs

 No oral formulations to allow step-down therapy

 Superinfection with even more resistant bacteria or fungi